Updated: 5/6/2020

Paget Disease of the Breast

0%
Topic
Review Topic
0
0
N/A
N/A
Questions
1 1
0
0
0%
0%
Evidence
2 2
0
0
https://upload.medbullets.com/topic/120426/images/snap.jpg
https://upload.medbullets.com/topic/120426/images/histo.jpg
https://upload.medbullets.com/topic/120426/images/paget.jpg
Snapshot
  • A 56-year-old woman presents to the physician with complaint of redness and itching in her left nipple. She says she has noticed that her areola has felt "rough and bumpy" and that there is occasional oozing of yellow pus from the skin around the nipple. Physical examination shows the finding seen in the image. The physician orders a mammogram and a punch biopsy of the skin around the nipple.
Introduction
  • Overview
    • Paget disease of the breast is a chronic, eczematous rash on the nipple and adjacent areolar skin
  • Epidemiology
    • incidence
      • occurs in 1-4% of cases of female breast cancer
        • underlying carcinoma is present in nearly 100% of cases
      • almost exclusively seen in women
        • < 2% of cases are seen in men
    • demographics
      • mean age at diagnosis is 55 years
  • Pathophysiology 
    • associated with an underlying breast carcinoma extension of malignant epithelial (Paget) cells through the lactiferous ducts and ductules into the epidermis
    • proliferation of malignant epithelial cells causes thickening of the nipple and surrounding areolar skin
  • Prognosis
    • dependent upon presence of the underlying invasive ductal carcinoma or axillary node metastases
    • Paget disease of the breast that presents with a palpable mass is usually associated with a worse prognosis than cases without a palpable mass
      • palpable mass and invasive ductal carcinoma: 5-year survival around 35-45%
      • no mass and invasive ductal carcinoma: 5-year survival around 90-100%
Presentation
  • Symptoms
    • erythema
    • scaling
    • itching and burning sensation
    • ulceration
    • oozing
    • bleeding
  • Physical exam
    • eczematous lesion involving the nipple and areolar areas
Imaging
  • Mammography
    • indications
      • locate underlying breast carcinoma
    • findings
      • subareolar microcalcifications
      • thickening of the nipple and areola
Studies
  • Scrape cytology
    • rapid diagnostic screening method
    • findings
      • presence of malignant Paget cells
  • Biopsy
    • punch, wedge, or excisional biopsy of the skin lesion in the nipple and areola
      • histologic features of Paget disease
        • hyperkeratosis, parakeratosis, and acanthosis of the epidermis
        • epidermal cells stain with antibodies against carcinoembryonic antigen
        • nests of malignant Paget cells in layers of the epidermis
          • clear cells with large, pleomorphic nuclei that spread individually into the epidermis ("pagetoid")
Differential
  • Bowen disease
    • key distinguishing factor
      • epidermal cells stain with antibodies to keratin and NOT to carcinoembryonic antigen
  • Cutaneous melanoma
    • key distinguishing factor
      • epidermal cells stain with antibodies to S-100 and NOT to carcinoembryonic antigen
  • Contact dermatitis
    • key distinguishing factor
      • onset of symptoms occurs after exposure to an irritant
Treatment
  • Surgical
    • mastectomy and lymph node dissection
      • indications
        • patients with Paget disease of the breast and underlying invasive breast carcinoma
 

Please rate topic.

Average 5.0 of 1 Ratings

Questions (1)
Lab Values
Blood, Plasma, Serum Reference Range
ALT 8-20 U/L
Amylase, serum 25-125 U/L
AST 8-20 U/L
Bilirubin, serum (adult) Total // Direct 0.1-1.0 mg/dL // 0.0-0.3 mg/dL
Calcium, serum (Ca2+) 8.4-10.2 mg/dL
Cholesterol, serum Rec: < 200 mg/dL
Cortisol, serum 0800 h: 5-23 μg/dL //1600 h:
3-15 μg/dL
2000 h: ≤ 50% of 0800 h
Creatine kinase, serum Male: 25-90 U/L
Female: 10-70 U/L
Creatinine, serum 0.6-1.2 mg/dL
Electrolytes, serum  
Sodium (Na+) 136-145 mEq/L
Chloride (Cl-) 95-105 mEq/L
Potassium (K+) 3.5-5.0 mEq/L
Bicarbonate (HCO3-) 22-28 mEq/L
Magnesium (Mg2+) 1.5-2.0 mEq/L
Estriol, total, serum (in pregnancy)  
24-28 wks // 32-36 wks 30-170 ng/mL // 60-280 ng/mL
28-32 wk // 36-40 wks 40-220 ng/mL // 80-350 ng/mL
Ferritin, serum Male: 15-200 ng/mL
Female: 12-150 ng/mL
Follicle-stimulating hormone, serum/plasma Male: 4-25 mIU/mL
Female: premenopause: 4-30 mIU/mL
midcycle peak: 10-90 mIU/mL
postmenopause: 40-250
pH 7.35-7.45
PCO2 33-45 mmHg
PO2 75-105 mmHg
Glucose, serum Fasting: 70-110 mg/dL
2-h postprandial:<120 mg/dL
Growth hormone - arginine stimulation Fasting: <5 ng/mL
Provocative stimuli: > 7ng/mL
Immunoglobulins, serum  
IgA 76-390 mg/dL
IgE 0-380 IU/mL
IgG 650-1500 mg/dL
IgM 40-345 mg/dL
Iron 50-170 μg/dL
Lactate dehydrogenase, serum 45-90 U/L
Luteinizing hormone, serum/plasma Male: 6-23 mIU/mL
Female: follicular phase: 5-30 mIU/mL
midcycle: 75-150 mIU/mL
postmenopause 30-200 mIU/mL
Osmolality, serum 275-295 mOsmol/kd H2O
Parathyroid hormone, serume, N-terminal 230-630 pg/mL
Phosphatase (alkaline), serum (p-NPP at 30° C) 20-70 U/L
Phosphorus (inorganic), serum 3.0-4.5 mg/dL
Prolactin, serum (hPRL) < 20 ng/mL
Proteins, serum  
Total (recumbent) 6.0-7.8 g/dL
Albumin 3.5-5.5 g/dL
Globulin 2.3-3.5 g/dL
Thyroid-stimulating hormone, serum or plasma .5-5.0 μU/mL
Thyroidal iodine (123I) uptake 8%-30% of administered dose/24h
Thyroxine (T4), serum 5-12 μg/dL
Triglycerides, serum 35-160 mg/dL
Triiodothyronine (T3), serum (RIA) 115-190 ng/dL
Triiodothyronine (T3) resin uptake 25%-35%
Urea nitrogen, serum 7-18 mg/dL
Uric acid, serum 3.0-8.2 mg/dL
Hematologic Reference Range
Bleeding time 2-7 minutes
Erythrocyte count Male: 4.3-5.9 million/mm3
Female: 3.5-5.5 million mm3
Erythrocyte sedimentation rate (Westergren) Male: 0-15 mm/h
Female: 0-20 mm/h
Hematocrit Male: 41%-53%
Female: 36%-46%
Hemoglobin A1c ≤ 6 %
Hemoglobin, blood Male: 13.5-17.5 g/dL
Female: 12.0-16.0 g/dL
Hemoglobin, plasma 1-4 mg/dL
Leukocyte count and differential  
Leukocyte count 4,500-11,000/mm3
Segmented neutrophils 54%-62%
Bands 3%-5%
Eosinophils 1%-3%
Basophils 0%-0.75%
Lymphocytes 25%-33%
Monocytes 3%-7%
Mean corpuscular hemoglobin 25.4-34.6 pg/cell
Mean corpuscular hemoglobin concentration 31%-36% Hb/cell
Mean corpuscular volume 80-100 μm3
Partial thromboplastin time (activated) 25-40 seconds
Platelet count 150,000-400,000/mm3
Prothrombin time 11-15 seconds
Reticulocyte count 0.5%-1.5% of red cells
Thrombin time < 2 seconds deviation from control
Volume  
Plasma Male: 25-43 mL/kg
Female: 28-45 mL/kg
Red cell Male: 20-36 mL/kg
Female: 19-31 mL/kg
Cerebrospinal Fluid Reference Range
Cell count 0-5/mm3
Chloride 118-132 mEq/L
Gamma globulin 3%-12% total proteins
Glucose 40-70 mg/dL
Pressure 70-180 mm H2O
Proteins, total < 40 mg/dL
Sweat Reference Range
Chloride 0-35 mmol/L
Urine  
Calcium 100-300 mg/24 h
Chloride Varies with intake
Creatinine clearance Male: 97-137 mL/min
Female: 88-128 mL/min
Estriol, total (in pregnancy)  
30 wks 6-18 mg/24 h
35 wks 9-28 mg/24 h
40 wks 13-42 mg/24 h
17-Hydroxycorticosteroids Male: 3.0-10.0 mg/24 h
Female: 2.0-8.0 mg/24 h
17-Ketosteroids, total Male: 8-20 mg/24 h
Female: 6-15 mg/24 h
Osmolality 50-1400 mOsmol/kg H2O
Oxalate 8-40 μg/mL
Potassium Varies with diet
Proteins, total < 150 mg/24 h
Sodium Varies with diet
Uric acid Varies with diet
Body Mass Index (BMI) Adult: 19-25 kg/m2
Calculator

Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Evidences (2)
Topic COMMENTS (0)
Private Note